Enterprise Value
27.2M
Cash
8.921M
Avg Qtr Burn
-2.733M
Short % of Float
4.18%
Insider Ownership
15.18%
Institutional Own.
12.48%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ibezapolstat (IBZ) Details Clostridioides difficile infection | Phase 3 Initiation |